Biliary Stent Market Size, Share & Industry Analysis, By Material (Metal, Plastic), By Applications (Malignant Obstruction, Benign Biliary Strictures, Biliary Leaks, Others), By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Research and Academic Institutes, Ambulance surgical Centers, Others) and Regional Forecast, 2026-2034

The global biliary stent market size was valued at USD 157.29 million in 2025. The market is projected to grow from USD 165.26 million in 2026 to USD 245.51 million by 2034, exhibiting a CAGR of 5.07% during the forecast period.

The Biliary Stent Market is a specialized segment within the gastrointestinal and interventional medical device industry, focused on restoring bile flow in patients with biliary obstruction. Biliary stents are commonly used in endoscopic and minimally invasive procedures to manage conditions affecting the bile ducts. The Biliary Stent Market Size is shaped by rising incidences of gallstones, pancreatic cancer, cholangiocarcinoma, and post-surgical biliary complications. Increasing preference for minimally invasive procedures and advancements in endoscopic technologies continue to drive product adoption. Manufacturers focus on improving stent patency, biocompatibility, and ease of deployment. The Biliary Stent Market Outlook remains favorable due to sustained demand from hospitals and specialty care centers.

The USA Biliary Stent Market represents one of the most technologically advanced and clinically active markets worldwide. The United States accounts for approximately 34% of the global Biliary Stent Market Share, supported by high procedure volumes, advanced healthcare infrastructure, and early adoption of minimally invasive techniques. Demand is driven by rising prevalence of biliary disorders, pancreatic malignancies, and an aging population. Hospitals and ambulatory surgical centers remain key end users. Strong reimbursement frameworks and access to advanced endoscopic equipment support innovation and product uptake. The Biliary Stent Industry Analysis in the USA highlights intense competition, continuous product upgrades, and strong collaboration between device manufacturers and healthcare providers.

Key Findings

Market Size & Growth

• Global market size 2025: USD 157.29  billion
• Global market size 2034: USD 245.51 billion
• CAGR (2025–2034): 5.07%

Market Share – Regional

• North America: 38%
• Europe: 27%
• Asia-Pacific:25%
• Middle East & Africa:10%

Country - Level Shares

• Germany:9% of Europe’s market
• United Kingdom:7% of Europe’s market
• Japan:8% of Asia-Pacific market
• China:11% of Asia-Pacific market

Biliary Stent Market Latest Trends

The Biliary Stent Market Trends reflect a growing shift toward advanced metal stents and fully covered self-expanding designs. One major trend is the increasing preference for self-expanding metal stents due to longer patency and reduced need for repeat interventions. These devices are increasingly used in malignant biliary obstructions where long-term drainage is required.

Another key Biliary Stent Market Insight is the rising adoption of minimally invasive endoscopic retrograde cholangiopancreatography procedures. Improved imaging and navigation technologies enable precise stent placement, reducing complications and recovery time. Biodegradable and drug-eluting biliary stents are also gaining research attention, aiming to reduce inflammation and restenosis.

The Biliary Stent Market Research Report highlights increased focus on patient-specific solutions, including varied diameters, lengths, and coatings. Hospitals are adopting value-based procurement, favoring devices that reduce readmissions. These trends collectively support continued Biliary Stent Market Growth across developed and emerging healthcare systems.

Download Free sample to learn more about this report.

Biliary Stent Market Dynamics

DRIVER

Rising prevalence of biliary and pancreatic disorders

The primary driver of Biliary Stent Market Growth is the increasing incidence of biliary tract diseases and pancreatic disorders. Conditions such as gallstones, strictures, cholangitis, and pancreatic cancer often result in bile duct obstruction requiring stent placement. Aging populations and lifestyle-related risk factors contribute to higher diagnosis rates.The Biliary Stent Industry Report indicates growing use of endoscopic interventions as first-line treatment, replacing traditional surgical approaches. Hospitals and gastroenterology centers rely heavily on biliary stents to manage both benign and malignant obstructions. Improved diagnostic imaging further supports early intervention, driving consistent demand for biliary stenting procedures.

RESTRAINT

Risk of complications and stent occlusion

A major restraint in the Biliary Stent Market is the risk of complications such as stent occlusion, migration, and infection. Plastic stents, in particular, have shorter patency and require frequent replacement. These limitations can increase procedure frequency and healthcare costs.The Biliary Stent Market Analysis highlights concerns related to biofilm formation and sludge accumulation, which reduce stent effectiveness. Regulatory scrutiny and the need for clinical validation also add development complexity. These factors can limit adoption in certain patient populations and healthcare settings.

OPPORTUNITY

Advancements in covered and biodegradable stents

The Biliary Stent Market Opportunities are strongly linked to technological advancements in covered metal and biodegradable stents. Fully covered self-expanding metal stents reduce tissue ingrowth and simplify removal, improving clinical outcomes.Research into biodegradable materials presents opportunities to eliminate stent removal procedures altogether. The Biliary Stent Market Forecast highlights strong interest from hospitals seeking long-term cost efficiency and reduced patient burden. These innovations open new growth avenues for manufacturers focusing on next-generation solutions.

CHALLENGE

High procedural costs and training requirements

One of the main challenges in the Biliary Stent Market is the high cost of advanced stents and specialized endoscopic procedures. Hospitals must invest in skilled personnel, training, and imaging systems to support biliary stenting.The Biliary Stent Industry Analysis indicates that limited access to advanced endoscopy in low-resource settings restricts market penetration. Ensuring consistent clinical outcomes across diverse healthcare environments remains a challenge for device manufacturers.

Biliary Stent Market Segmentation

By Material

Metal biliary stents account for approximately 58% of the Biliary Stent Market Share, making them the most dominant product category globally. These stents are widely used in cases of malignant biliary obstruction where long-term bile duct patency is required. Self-expanding metal stents provide a larger lumen diameter, which improves bile flow and reduces the risk of early occlusion.

Hospitals and specialty gastroenterology centers prefer metal stents due to their superior durability and resistance to external compression from tumors. Covered metal stents are increasingly favored as they minimize tissue ingrowth and simplify stent removal when necessary. The Biliary Stent Market Analysis highlights their strong adoption in palliative cancer care, where reducing repeat interventions is a priority. Although metal stents have higher upfront costs, their extended functional lifespan lowers overall treatment burden. Continuous advancements in coating materials and delivery systems further strengthen the position of metal biliary stents within the Biliary Stent Industry Outlook.

Plastic biliary stents hold approximately 42% of the Biliary Stent Market Size, maintaining strong relevance across both developed and emerging healthcare systems. These stents are commonly used for benign biliary strictures, biliary leaks, and short-term drainage following surgical procedures. Plastic stents are valued for their affordability, ease of placement, and simple removal during follow-up procedures.The Biliary Stent Industry Report indicates widespread use of plastic stents in initial management strategies and temporary interventions. They are particularly suitable for patients requiring frequent stent exchanges or short-duration treatment. Despite their shorter patency compared to metal stents, plastic stents remain essential in cost-sensitive healthcare settings. Hospitals and ambulatory centers often rely on plastic stents for post-operative complications and inflammatory conditions. Ongoing improvements in polymer materials and stent design continue to enhance performance and clinical reliability.

By Application

Malignant obstruction represents approximately 46% of the Biliary Stent Market Share, making it the largest application segment. This dominance is driven by increasing incidence of pancreatic cancer, cholangiocarcinoma, and metastatic tumors causing bile duct compression. Biliary stenting is a critical palliative intervention used to relieve jaundice, improve liver function, and enhance patient quality of life.Metal biliary stents are the preferred choice in this segment due to their longer patency and reduced need for replacement. The Biliary Stent Market Analysis highlights strong reliance on self-expanding metal stents for long-term drainage in advanced cancer cases. Hospitals prioritize solutions that minimize repeat procedures and hospital readmissions. As oncology care increasingly emphasizes minimally invasive palliation, demand within this application segment remains consistently high across global healthcare markets.

Benign biliary strictures account for approximately 32% of the Biliary Stent Market, commonly arising from post-surgical complications, chronic pancreatitis, or inflammatory diseases. These conditions typically require temporary bile duct support rather than permanent stenting. Plastic biliary stents are widely used due to their removability and cost efficiency.The Biliary Stent Market Research Report highlights steady procedural volumes associated with benign strictures, often requiring multiple stent exchanges over time. Hospitals prefer flexible treatment approaches that allow gradual duct dilation and healing. Endoscopic management using plastic stents remains the standard of care in many cases. Continued growth in minimally invasive gastrointestinal procedures supports sustained demand within this application segment.

Biliary leaks represent approximately 14% of the Biliary Stent Market Share, frequently occurring as complications following gallbladder surgery or liver transplantation. Stent placement helps divert bile away from the leak site, allowing natural healing of the biliary tract.Plastic stents are predominantly used in this segment due to their short-term application and ease of removal. The Biliary Stent Market Analysis indicates strong adoption in post-operative care protocols, particularly in hospitals performing high volumes of hepatobiliary surgeries. Prompt stent placement reduces infection risk and shortens recovery time. As surgical volumes continue to rise globally, biliary leak management remains an important contributor to overall market demand.

Other applications collectively account for approximately 8% of the Biliary Stent Market Share, including traumatic bile duct injuries, congenital biliary abnormalities, and rare anatomical conditions. Although this segment is smaller, it plays a critical role in addressing complex and specialized clinical scenarios.The Biliary Stent Industry Report highlights that treatment approaches in this segment are highly individualized, often requiring customized stent sizes and configurations. Both metal and plastic stents may be used depending on clinical complexity. Specialized tertiary care centers drive most demand within this category. While niche in volume, these applications contribute to product innovation and diversification within the Biliary Stent Market Outlook.

By End User

Hospitals account for approximately 46% of the Biliary Stent Market Share, making them the largest end-user segment globally. Biliary stent procedures are most frequently performed in hospital settings due to the need for advanced imaging, endoscopic equipment, and multidisciplinary clinical expertise. Hospitals handle high volumes of both emergency and elective biliary interventions, including malignant obstruction management, post-surgical complications, and complex hepatobiliary cases.From a B2B perspective, hospitals demand a wide portfolio of biliary stents, including metal and plastic variants, to address diverse clinical indications. Procurement decisions are influenced by clinical outcomes, stent patency, ease of deployment, and compatibility with existing endoscopic systems. Teaching hospitals and tertiary care centers also drive adoption of advanced covered metal stents. High procedural volumes, strong reimbursement frameworks, and availability of skilled gastroenterologists reinforce hospitals’ dominant role in the Biliary Stent Market Outlook.

Specialty clinics represent approximately 21% of the Biliary Stent Market Share, driven by the growing number of dedicated gastroenterology and hepatobiliary care centers. These clinics focus on minimally invasive diagnostic and therapeutic procedures, including endoscopic biliary stenting for benign and malignant conditions. Specialty clinics benefit from streamlined workflows, shorter patient wait times, and targeted expertise.The Biliary Stent Market Analysis highlights increasing procedural migration from large hospitals to specialty clinics, particularly for routine and follow-up stenting procedures. Clinics favor cost-effective plastic stents for temporary indications and selectively use metal stents for complex cases. Device selection emphasizes ease of handling, reliability, and consistent clinical performance. As outpatient care models expand, specialty clinics continue to gain importance as high-volume, efficiency-driven end users in the biliary stent ecosystem.

Diagnostic laboratories account for approximately 6% of the Biliary Stent Market Share, primarily through their role in interventional diagnostic and image-guided procedures. While traditional laboratories focus on diagnostics, advanced diagnostic centers increasingly perform minimally invasive interventions in collaboration with gastroenterologists and radiologists.In this setting, biliary stents are used during image-guided procedures to confirm duct patency, manage temporary obstructions, or support diagnostic workflows. The Biliary Stent Industry Report indicates that demand from diagnostic laboratories is concentrated in urban and specialized centers with interventional capabilities. These end users prioritize precision, compatibility with imaging systems, and procedural efficiency. Although smaller in volume, diagnostic laboratories contribute to market diversification and support early intervention strategies within the broader biliary care pathway.

Research and academic institutes represent approximately 8% of the Biliary Stent Market Share, playing a critical role in clinical research, product evaluation, and procedural training. These institutions conduct clinical trials, comparative studies, and innovation-driven research focused on improving biliary stent design, materials, and clinical outcomes.The Biliary Stent Market Analysis highlights strong demand from academic centers for a wide range of stent types to support experimental protocols and educational programs. Teaching hospitals and research institutes also serve as early adopters of next-generation stents, including covered and biodegradable designs. Collaboration between manufacturers and academic institutions accelerates product validation and regulatory approval. While not the largest consumers by volume, these end users significantly influence technology adoption and future market direction.

Ambulatory surgical centers (ASCs) account for approximately 13% of the Biliary Stent Market Share, reflecting the shift toward outpatient and same-day minimally invasive procedures. ASCs perform biliary stenting for selected patient populations, particularly those requiring short-term drainage or routine follow-up interventions.The Biliary Stent Market Research Report indicates that ASCs favor portable, easy-to-deploy stent systems that support rapid patient turnover. Plastic stents are commonly used due to cost efficiency and short-term application needs. ASCs prioritize procedural speed, safety, and infection control. As healthcare systems increasingly emphasize cost reduction and outpatient care, ASCs are expected to play a growing role in biliary stent utilization.

Other end users collectively account for approximately 6% of the Biliary Stent Market Share, encompassing emergency units, mobile surgical teams, military healthcare facilities, and limited home-based care scenarios. These settings typically involve urgent or specialized use cases rather than routine biliary stenting.The Biliary Stent Market Insights highlight that demand in this segment is driven by emergency management of biliary obstruction and post-trauma care. Devices used in these environments must be reliable, easy to transport, and compatible with limited infrastructure. Although smaller in volume, this segment highlights the versatility and expanding clinical reach of biliary stent technologies within diverse healthcare delivery models.

Biliary Stent Market Regional Outlook

North America 

North America holds approximately 38% of the Biliary Stent Market Share, making it the largest regional market globally. This leadership is driven by a high volume of endoscopic retrograde cholangiopancreatography procedures and widespread adoption of minimally invasive biliary interventions. The region benefits from a well-established healthcare infrastructure, advanced diagnostic imaging, and strong clinical expertise in gastroenterology and hepatobiliary care.Hospitals and ambulatory surgical centers are the primary end users, with increasing preference for self-expanding metal biliary stents in malignant obstruction cases. Favorable reimbursement policies support the use of advanced stent technologies, including covered and drug-eluting designs. Continuous clinical research, early adoption of innovative devices, and strong collaboration between manufacturers and healthcare providers further reinforce North America’s dominance. Rising prevalence of pancreatic cancer and biliary disorders continues to sustain demand across the region.

Europe 

Europe accounts for approximately 27% of the global Biliary Stent Market Share, supported by aging populations, increasing cancer incidence, and strong public healthcare systems. Biliary stenting is a standard clinical practice across major European countries, particularly for managing malignant and benign biliary obstructions. Hospitals emphasize evidence-based treatment pathways and cost-effectiveness when selecting biliary stent solutions.Strict regulatory frameworks influence product approval, quality assurance, and clinical adoption. This drives demand for stents with proven safety, durability, and clinical outcomes. Endoscopic expertise is widely available across tertiary care centers, supporting consistent procedural volumes. The market also benefits from increasing use of minimally invasive approaches over surgical interventions. Europe remains a stable and innovation-driven region within the global Biliary Stent Market Outlook.

Germany Biliary Stent Market 

Germany represents approximately 9% of the global Biliary Stent Market Share, positioning it as the largest country-level market in Europe. The country’s advanced healthcare system places strong emphasis on early diagnosis and minimally invasive management of biliary disorders. High availability of specialized gastroenterology centers supports frequent use of biliary stents.German hospitals prioritize high-quality metal stents with extended patency for malignant obstruction cases. Strong clinical research activity and adherence to standardized treatment guidelines influence purchasing decisions. The presence of advanced endoscopic equipment and trained specialists ensures consistent demand. Germany’s focus on precision medicine and quality outcomes sustains its significant contribution to the European biliary stent market.

United Kingdom Biliary Stent Market 

The United Kingdom holds approximately 7% of the global Biliary Stent Market Share, driven by centralized healthcare delivery and standardized treatment protocols. Biliary stenting is widely used within the public healthcare system for managing gallstone disease, strictures, and cancer-related obstructions.Cost-effectiveness and clinical evidence play a major role in procurement decisions. Hospitals increasingly favor metal stents for long-term management and plastic stents for temporary drainage. Growing adoption of minimally invasive endoscopic procedures supports market stability. National screening and referral pathways contribute to steady procedural volumes. The UK market remains focused on balancing clinical outcomes with cost efficiency.

Asia-Pacific 

Asia-Pacific represents approximately 25% of the global Biliary Stent Market Size, making it one of the fastest-developing regional markets. Growth is supported by expanding healthcare infrastructure, rising awareness of biliary diseases, and increasing access to endoscopic care. Large patient populations and improving diagnostic capabilities contribute to growing procedural volumes.Hospitals are increasingly adopting biliary stents as minimally invasive alternatives to surgery. Government investments in healthcare modernization and specialty care centers support adoption. Cost-effective plastic stents remain widely used, while demand for metal stents is increasing in urban and tertiary hospitals. The region offers strong long-term growth potential within the global Biliary Stent Market Outlook.

Japan Biliary Stent Market 

Japan accounts for approximately 8% of the global Biliary Stent Market Share, driven by advanced medical technology adoption and a rapidly aging population. Biliary stenting is a routine procedure in managing malignant and benign biliary conditions, particularly among elderly patients.Japanese healthcare providers emphasize precision, safety, and long-term clinical outcomes. Metal stents with advanced coatings are widely used in cancer-related obstructions. Strong clinical expertise and high procedural standards support consistent demand. Japan’s focus on minimally invasive treatment and quality-driven care sustains its stable position in the Asia-Pacific biliary stent market.

China Biliary Stent Market

China holds approximately 11% of the global Biliary Stent Market Share, making it the largest country-level contributor in Asia-Pacific. Rapid healthcare expansion, rising cancer incidence, and growing access to endoscopic procedures drive demand. Large urban hospitals perform high volumes of biliary stenting procedures.Domestic manufacturing supports availability and cost efficiency, particularly for plastic stents. Adoption of metal stents is increasing as tertiary care facilities expand. Government healthcare reforms and investments in specialty hospitals continue to improve access to advanced biliary interventions. China’s scale and modernization efforts position it as a key growth driver in the global biliary stent market.

Middle East & Africa 

The Middle East & Africa region holds approximately 10% of the global Biliary Stent Market Share, representing an emerging but steadily expanding market. Growth is supported by increasing investment in tertiary healthcare facilities and rising awareness of minimally invasive gastrointestinal treatments.Hospitals in urban centers are the primary end users, with growing adoption of biliary stents for managing cancer-related obstructions. Import dependency remains high, but access to advanced endoscopic care is improving. Training initiatives and international collaborations support skill development. As healthcare infrastructure continues to expand, the region presents untapped opportunities within the global Biliary Stent Market Outlook.

List of Top Biliary Stent Companies

• Boston Scientific Corporation
• Cook
• Medtronic
• Richard Wolf GmbH
• Olympus Corporation
• BD
• Stryker
• CONMED Corporation
• KARL STORZ

Top Two Companies by Market Share

• Boston Scientific Corporation – 22% Market Share
• Medtronic – 17% Market Share

Investment Analysis and Opportunities

Investment activity in the Biliary Stent Market is increasingly directed toward innovation in minimally invasive gastrointestinal technologies and advanced biomaterials. Manufacturers are allocating capital to improve stent durability, flexibility, and long-term patency to meet evolving clinical demands. Significant investment is being made in research programs focused on reducing stent occlusion and migration risks.

Opportunities are expanding in emerging economies where access to endoscopic procedures is improving through healthcare infrastructure development. Strategic collaborations between device manufacturers, hospitals, and academic research institutes support clinical validation and faster adoption of new stent technologies. Investors show strong interest in companies with diversified biliary portfolios, regulatory experience, and proven clinical outcomes. Expansion of cancer treatment centers and rising demand for palliative care further enhance the attractiveness of the biliary stent segment as a stable medical device investment area.

New Product Development

New product development in the Biliary Stent Market is centered on advancing covered metal stent technologies and next-generation biodegradable solutions. Manufacturers are focusing on improving stent coatings to reduce tissue ingrowth, biofilm formation, and inflammatory responses. Enhanced delivery systems are being designed to allow more precise placement during endoscopic procedures.

Innovation efforts also target anti-migration features and improved radial force control to enhance procedural safety. Compatibility with advanced endoscopic imaging and navigation tools is a key development priority. Companies are introducing stents in a wider range of diameters and lengths to address patient-specific anatomical needs. These product advancements aim to improve clinical outcomes, reduce repeat interventions, and strengthen the competitive positioning of biliary stent manufacturers globally.

Five Recent Developments (2023–2025)

• Launch of fully covered self-expanding metal biliary stents
• Expansion of biodegradable stent research programs
• Introduction of enhanced delivery catheter systems
• Strategic collaborations with gastroenterology centers
• Regulatory approvals for next-generation biliary stents

Report Coverage of Biliary Stent Market

This Biliary Stent Market Report delivers a detailed and structured assessment of the global industry, covering product types, clinical applications, end-user segments, and regional performance. The report provides comprehensive analysis of the Biliary Stent Market Size, market share distribution, and evolving market structure to support strategic planning and competitive benchmarking. It evaluates key Biliary Stent Market Trends influencing adoption across hospitals, specialty clinics, and ambulatory surgical centers.

The coverage includes in-depth examination of clinical practices, procedural workflows, and treatment pathways related to biliary obstruction management. Regulatory environments, product approval frameworks, and quality standards across major regions are analyzed to support compliance planning. The report also explores technological advancements such as covered metal stents, biodegradable materials, and improved delivery systems. Competitive landscape analysis highlights leading manufacturers, product portfolios, and market positioning. Overall, the report is designed to provide actionable Biliary Stent Industry Insights for manufacturers, healthcare providers, investors, and B2B decision-makers.

Request for Customization   to gain extensive market insights.